Researchers have revealed a proof of principle clinical trial that used a high dose ‘blast’ of a specially engineered version of the measles virus to cure cancer.
Researchers have revealed a proof of principle clinical trial that used a high dose ‘blast’ of a specially engineered version of the measles virus to cure cancer.